Neuroendocrine Prostate Cancer Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Neuroendocrine Prostate Cancer Market is segmented By Treatment (Chemotherapy, Hormonal Therapy), By Stage of Disease (Localized, Metastatic), By Therapeutics (Immunotherapy, Targeted Therapy), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.
Neuroendocrine Prostate Cancer Market Size
Market Size in USD
CAGR7.1%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 7.1% |
| Market Concentration | Medium |
| Major Players | Amgen, BioXcel Therapeutics, Oric Pharmaceuticals, Xencor, Astellas Pharma/Medivation |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Neuroendocrine Prostate Cancer Market Analysis
The neuroendocrine prostate cancer market is estimated to be valued at USD 964.1 Mn in 2024 and is expected to reach USD 1,560.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031. The increasing prevalence of prostate cancer globally is expected to drive the demand for effective treatment options.